Cited by 166HIV Research and TreatmentVirus-based gene therapy researchHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART

Open access

Wiegand, Ann, Spindler, Jonathan, Hong, Feiyu F., Shao, Wei, Cyktor, Joshua C., Cillo, Anthony R., Halvas, Elias K., Coffin, John M., Mellors, John W., Kearney, Mary F.·2017·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1617961114PMC PMC5422779

Open this paper in CoChat — free account

Abstract

Significance: Previously, we showed that the virus that persists in human immunodeficiency virus (HIV)-infected individuals on antiretroviral therapy (ART) is derived from cells infected prior to initiating treatment. We also showed that HIV-infected cells can undergo cellular proliferation during ART. However, it is not known what fraction of infected cells that persist during ART are latent and what fraction are actively producing HIV RNA. The method described here was developed to determine the fraction of infected cells that produce HIV RNA and the levels of HIV RNA in single cells, including cells that have undergone cellular proliferation. Additionally, the method can be used to identify the sources of rebound virus after stopping ART and the efficacy of experimental interventions designed to cure HIV infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.1617961114

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.
Tamura, K., Stecher, G., Peterson, D., Filipski, A., & Kumar, S. (2013) · Molecular biology and evolution · doi:10.1093/molbev/mst197 · Cited by 41,174
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T. B., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,913
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
Maldarelli, F., Wu, X., Su, L., Simonetti, F. R., Shao, W., Hill, S., Spindler, J., Ferris, A. L., Mellors, J. W., Kearney, M. F., et al. (2014) · Science · doi:10.1126/science.1254194 · Cited by 849
Self-citation
Defective proviruses rapidly accumulate during acute HIV-1 infection
Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.
Folks, T. M., Clouse, K. A., Justement, J. S., Rabson, A. B., Duh, E. J., Kehrl, J. H., & Fauci, A. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2365 · Cited by 701
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
Wagner, T. A., McLaughlin, S., Garg, K., Cheung, C. Y. K., Larsen, B. B., Styrchak, S., Huang, H. C., Edlefsen, P. T., Mullins, J. I., & Frenkel, L. M. (2014) · Science · doi:10.1126/science.1256304 · Cited by 677
Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis
Palmer, S., Kearney, M., Maldarelli, F., Halvas, E. K., Bixby, C. J., Bazmi, H., Rock, D., Falloon, J., Davey, R. T., Dewar, R. L., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.406-413.2005 · Cited by 506
Self-citation
HIV-1 Integration Landscape during Latent and Active Infection
Cohn, L. B., da Silva, I. T., Oliveira, T. Y., Rosales, R., Parrish, E. H., Learn, G. H., Hahn, B. H., Czartoski, J., McElrath, M. J., Lehmann, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.020 · Cited by 460
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
Dinoso, J. B., Kim, S. Y., Wiegand, A. P., Palmer, S., Gange, S. J., Cranmer, L. M., O'Shea, A., Callender, M., Spivak, A. M., Brennan, T. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 452
Self-citation

Show all 44 references

Sorted by citations

HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy
Ganor, Y., Real, F., Sennepin, A., Dutertre, C., Prevedel, L., Xu, L., Tudor, D., Muylder, B. C.-D., Couëdel-Courteille, A., Marion, S., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0335-z · Cited by 295
The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies
Cohn, L. B., Chomont, N., & Deeks, S. G. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.014 · Cited by 296
Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses
Einkauf, K. B., Osborn, M. R., Gao, C., Sun, W., Sun, X., Lian, X., Parsons, E. M., Gladkov, G. T., Seiger, K. W., Blackmer, J. E., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.011 · Cited by 260
Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion
Pinzone, M. R., VanBelzen, J., Weissman, S., Bertuccio, M. P., Cannon, L., Rullo, E. V., Migueles, S. A., Jones, R. B., Mota, T. M., Joseph, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08431-7 · Cited by 179
Why and where an HIV cure is needed and how it might be achieved
Ndung’u, T., McCune, J. M., & Deeks, S. G. (2019) · Nature · doi:10.1038/s41586-019-1841-8 · Cited by 153
HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus
Halvas, E. K., Joseph, K. W., Brandt, L. D., Guo, S., Sobolewski, M. D., Jacobs, J. L., Tumiotto, C., Bui, J. K., Cyktor, J. C., Keele, B. F., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138099 · Cited by 145
Self-citation
Exosomes containing HIV protein Nef reorganize lipid rafts potentiating inflammatory response in bystander cells
Mukhamedova, N., Hoang, A., Dragoljevic, D., Dubrovsky, L., Pushkarsky, T., Low, H., Ditiatkovski, M., Fu, Y., Ohkawa, R., Meikle, P. J., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007907 · Cited by 133
Barriers and strategies to achieve a cure for HIV
Pitman, M. C., Lau, J. S. Y., McMahon, J. H., & Lewin, S. R. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30039-0 · Cited by 132
Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile
García‐Broncano, P., Maddali, S., Einkauf, K. B., Jiang, C., Gao, C., Chevalier, J. M., Chowdhury, F. Z., Maswabi, K., Ajibola, G., Moyo, S. M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax7350 · Cited by 121
Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir
Mendoza, P., Jackson, J., Oliveira, T. Y., Gaebler, C., Ramos, V., Caskey, M. F., Janković, M., Nussenzweig, M. C., & Cohn, L. B. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200051 · Cited by 122
HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy
McManus, W. R., Bale, M. J., Spindler, J., Wiegand, A. P., Musick, A., Patro, S. C., Sobolewski, M. D., Musick, V. K., Anderson, E. M., Cyktor, J. C., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126714 · Cited by 114
Self-citation
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection
Leyre, L., Kroon, E. D. M. B., Vandergeeten, C., Sacdalan, C., Colby, D. J., Buranapraditkun, S., Schuetz, A., Chomchey, N., de Souza, M. S., Bakeman, W., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aav3491 · Cited by 112
Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency
Bradley, T., Ferrari, G., Haynes, B. F., Margolis, D. M., & Browne, E. P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.020 · Cited by 106
Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART
Gantner, P., Pagliuzza, A., Pardons, M., Ramgopal, M. N., Routy, J., Fromentin, R., & Chomont, N. (2020) · Nature Communications · doi:10.1038/s41467-020-17898-8 · Cited by 104
A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir
Levy, C., Hughes, S. M., Roychoudhury, P., Reeves, D. B., Amstuz, C., Zhu, H., Huang, M.-L. W., Wei, Y., Bull, M. E., Cassidy, N. A. J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100243 · Cited by 98
The multifaceted nature of HIV latency
Dufour, C., Gantner, P., Fromentin, R., & Chomont, N. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136227 · Cited by 104
Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART
Pasternak, A. O., Grijsen, M. L., Wit, F. W. N. M., Bakker, M. E., Jurriaans, S., Prins, J. M., & Berkhout, B. (2020) · JCI Insight · doi:10.1172/jci.insight.134196 · Cited by 96
Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy
White, J. A., Simonetti, F. R., Beg, S. A., McMyn, N. F., Dai, W., Bachmann, N., Lai, J., Ford, W. C., Bunch, C., Jones, J. L., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2120326119 · Cited by 90
Clonally expanded HIV-1 proviruses with 5′-leader defects can give rise to nonsuppressible residual viremia
White, J. A., Wu, F., Yasin, S., Moskovljevic, M., Varriale, J., Dragoni, F., Camilo-Contreras, A., Duan, J., Zheng, M. Y., Tadzong, N. F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165245 · Cited by 89
Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells
Dubé, M., Tastet, O., Dufour, C., Sannier, G., Brassard, N., Ortega-Delgado, G.-G., Pagliuzza, A., Richard, C., Nayrac, M., Routy, J., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.006 · Cited by 87
What do we measure when we measure cell-associated HIV RNA
Pasternak, A. O., & Berkhout, B. (2018) · Retrovirology · doi:10.1186/s12977-018-0397-2 · Cited by 90
Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines
McCauley, S. M., Kim, K., Nowosielska, A., Dauphin, A., Yurkovetskiy, L., Diehl, W. E., & Luban, J. (2018) · Nature Communications · doi:10.1038/s41467-018-07753-2 · Cited by 78
Longitudinal study reveals HIV-1–infected CD4+ T cell dynamics during long-term antiretroviral therapy
Antar, A. A. R., Jenike, K. M., Jang, S., Rigau, D. N., Reeves, D. B., Hoh, R., Krone, M., Keruly, J. C., Moore, R. D., Schiffer, J. T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135953 · Cited by 82
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers
Sharaf, R., Lee, G. Q., Sun, X., Etemad, B., Aboukhater, L. M., Hu, Z., Brumme, Z. L., Aga, E., Bosch, R. J., Wen, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120549 · Cited by 83
The forces driving clonal expansion of the HIV-1 latent reservoir
Liu, R., Simonetti, F. R., & Ho, Y. (2020) · Virology Journal · doi:10.1186/s12985-019-1276-8 · Cited by 79
No evidence of HIV replication in children on antiretroviral therapy
van Zyl, G. U., Katusiime, M. G., Wiegand, A. P., McManus, W. R., Bale, M. J., Halvas, E. K., Luke, B. T., Boltz, V. F., Spindler, J., Laughton, B., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94582 · Cited by 78
Self-citation
HIV evolution and diversity in ART-treated patients
van Zyl, G. U., Bale, M. J., & Kearney, M. F. (2018) · Retrovirology · doi:10.1186/s12977-018-0395-4 · Cited by 77
Self-citation
The role of integration and clonal expansion in HIV infection: live long and prosper
Anderson, E. M., & Maldarelli, F. M. (2018) · Retrovirology · doi:10.1186/s12977-018-0448-8 · Cited by 75
Integrating Immunology and Microfluidics for Single Immune Cell Analysis
Sinha, N., Subedi, N., & Tel, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02373 · Cited by 72
Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir
Wang, Z., Simonetti, F. R., Siliciano, R. F., & Laird, G. M. (2018) · Retrovirology · doi:10.1186/s12977-018-0404-7 · Cited by 70
HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs
Fromentin, R., & Chomont, N. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101438 · Cited by 70
Between a shock and a hard place: challenges and developments in HIV latency reversal
Zerbato, J. M., Purves, H. V., Lewin, S. R., & Rasmussen, T. A. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.03.004 · Cited by 75
New Frontiers in Measuring and Characterizing the HIV Reservoir
Falcinelli, S. D., Ceriani, C., Margolis, D. M., & Archin, N. M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02878 · Cited by 65
The multifaceted nature of HIV latency
Dufour, C., Gantner, P., Fromentin, R., & Chomont, N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151380 · Cited by 63
Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy
Singh, K., Natarajan, V., Dewar, R. L., Rupert, A. W., Badralmaa, Y., Zhai, T., Winchester, N., Scrimieri, F., Smith, M., Davis, I., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003667 · Cited by 62
HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus
Musick, A., Spindler, J., Boritz, E., Pérez, L., Crespo-Vélez, D., Patro, S. C., Sobolewski, M. D., Bale, M. J., Reid, C., Keele, B. F., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02204 · Cited by 57
Self-citation
Immune Control of HIV
Balasubramaniam, M., Pandhare, J., & Dash, C. (2019) · JoLS Journal of Life Sciences · doi:10.36069/jols/20190603 · Cited by 55
Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors
Jefferys, S. R., Burgos, S. D., Peterson, J. J., Selitsky, S. R., Turner, A. W., James, L. I., Tsai, Y., Coffey, A. R., Margolis, D. M., Parker, J. S., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009346 · Cited by 47
The cell biology of HIV-1 latency and rebound
Mbonye, U. R., & Karn, J. (2024) · Retrovirology · doi:10.1186/s12977-024-00639-w · Cited by 57
Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency
Zerbato, J. M., Khoury, G., Zhao, W. D., Gartner, M. J., Pascoe, R. D., Rhodes, A., Dantanarayana, A., Gooey, M., Anderson, J. L., Bacchetti, P., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103241 · Cited by 45
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells
Nathan L. Board, Yuan, Z., Wu, F., Moskovljevic, M., Ravi, M., Sengupta, S., Mun, S. S., Simonetti, F. R., Lai, J., Tebas, P., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01741-5 · Cited by 50
Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
Jacobs, J. L., Halvas, E. K., Tosiano, M. A., & Mellors, J. W. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02383 · Cited by 50
Self-citation
An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses
Wells, D., Guo, S., Shao, W., Bale, M. J., Coffin, J. M., Hughes, S. H., & Wu, X. (2020) · BMC Genomics · doi:10.1186/s12864-020-6647-4 · Cited by 46
Self-citation
Defective HIV-1 genomes and their potential impact on HIV pathogenesis
Kuniholm, J., Coote, C., & Henderson, A. J. (2022) · Retrovirology · doi:10.1186/s12977-022-00601-8 · Cited by 46
Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection
Lau, C., Adan, M. A., & Maldarelli, F. M. (2021) · Viruses · doi:10.3390/v13122512 · Cited by 45
HIV Reservoirs and Treatment Strategies toward Curing HIV Infection
Matsuda, K., & Maeda, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052621 · Cited by 43
Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals
Wonderlich, E. R., Subramanian, K., Cox, B. D., Wiegand, A. P., Lackman-Smith, C., Bale, M. J., Stone, M., Hoh, R., Kearney, M. F., Maldarelli, F. M., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008074 · Cited by 43
Self-citation
CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
Darcis, G., Kootstra, N. A., Hooibrink, B., van Montfort, T., Maurer, I., Groen, K., Jurriaans, S., Bakker, M. E., Lint, C. M. V., Berkhout, B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.071 · Cited by 46
Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy
Sun, C., Liu, L., Pérez, L., Li, X., Liu, Y., Xu, P., Boritz, E., Mullins, J. I., & Abate, A. R. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00864-8 · Cited by 46
Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses
Weymar, G. H. J., Bar‐On, Y., Oliveira, T. Y., Gaebler, C., Ramos, V., Hartweger, H., Breton, G., Caskey, M. F., Cohn, L. B., Janković, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111311 · Cited by 42
HIV integration sites and implications for maintenance of the reservoir
Symons, J., Cameron, P. U., & Lewin, S. R. (2017) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000438 · Cited by 45
Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans
Ferris, A. L., Wells, D. W., Guo, S., Prete, G. Q. D., Swanstrom, A. E., Coffin, J. M., Wu, X., Lifson, J. D., & Hughes, S. H. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007869 · Cited by 39
Self-citation
Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
Anderson, E. M., Simonetti, F. R., Gorelick, R. J., Hill, S., Gouzoulis, M. A., Bell, J., Rehm, C. A., Pérez, L., Boritz, E., Wu, X., et al. (2020) · Viruses · doi:10.3390/v12020136 · Cited by 41
Self-citation
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
Cadena, A. M., Ventura, J. D., Abbink, P., Borducchi, E. N., Tuyishime, H., Mercado, N. B., Walker-Sperling, V. E. K., Siamatu, M., Liu, P.-T., Chandrashekar, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21724-0 · Cited by 40
An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection
Lichterfeld, M. D., Gao, C., & Yu, X. G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.06.002 · Cited by 41
Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations
Hikichi, Y., Duyne, R. V., Pham, P., Groebner, J. L., Wiegand, A. P., Mellors, J. W., Kearney, M. F., & Freed, E. O. (2021) · mBio · doi:10.1128/mbio.03134-20 · Cited by 38
Self-citation
HIV persistence: silence or resistance?
Pasternak, A. O., & Berkhout, B. (2023) · Current Opinion in Virology · doi:10.1016/j.coviro.2023.101301 · Cited by 43
Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART
Riddler, S. A., Zheng, L., Durand, C. M., Ritz, J., Koup, R. A., Ledgerwood, J. E., Bailer, R. T., Koletar, S. L., Eron, J. J., Keefer, M. C., et al. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy242 · Cited by 38
Self-citation
Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities
León‐Rivera, R., Morsey, B., Niu, M., Fox, H. S., & Berman, J. W. (2020) · mBio · doi:10.1128/mbio.01037-20 · Cited by 33
Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4 + T Cells
Obregon-Perko, V., Bricker, K. M., Mensah, G., Uddin, F., Kumar, M. R., Fray, E. J., Siliciano, R. F., Schoof, N., Horner, A. M., Mavigner, M., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01669-20 · Cited by 33
IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus
Guney, M. H., Nagalekshmi, K., McCauley, S. M., Carbone, C., Aydemir, Ö., & Luban, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2404349121 · Cited by 28
Next-generation bNAbs for HIV-1 cure strategies
Schriek, A. I., Aldon, Y., van Gils, M. J., & de Taeye, S. W. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105788 · Cited by 29
Current Strategies for Elimination of HIV-1 Latent Reservoirs Using Chemical Compounds Targeting Host and Viral Factors
Jean, M. J., Fiches, G. N., Hayashi, T., & Zhu, J. K. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0153 · Cited by 31
Clonal Expansion of Infected CD4+ T Cells in People Living with HIV
Coffin, J. M., & Hughes, S. H. (2021) · Viruses · doi:10.3390/v13102078 · Cited by 26
Self-citation
Single-Cell Analysis Reveals Heterogeneity of Virus Infection, Pathogenicity, and Host Responses: HIV as a Pioneering Example
Brandt, L., Cristinelli, S., & Ciuffi, A. (2020) · Annual Review of Virology · doi:10.1146/annurev-virology-021820-102458 · Cited by 25
Persistent HIV-1 transcription during ART: time to reassess its significance?
Fombellida-Lopez, C., Berkhout, B., Darcis, G., & Pasternak, A. O. (2024) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000849 · Cited by 24
Proviral location affects cognate peptide–induced virus production and immune recognition of HIV-1–infected T cell clones
Dragoni, F., Kwaa, A. K., Traut, C. C., Veenhuis, R. T., Woldemeskel, B. A., Camilo-Contreras, A., Raymond, H. E., Dykema, A. G., Scully, E. P., Rosecrans, A. M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171097 · Cited by 24
Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure
Khan, S., Telwatte, S., Trapečar, M., Yukl, S. A., & Sanjabi, S. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0153 · Cited by 27
Single-molecule techniques to quantify and genetically characterise persistent HIV
Wang, X. Q., & Palmer, S. (2018) · Retrovirology · doi:10.1186/s12977-017-0386-x · Cited by 23
Review
Bale, M. J., & Kearney, M. F. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000535 · Cited by 45
Self-citation
Detection of HPV E7 Transcription at Single-Cell Resolution in Epidermis
Lukowski, S. W., Tuong, Z. K., Nöske, K., Senabouth, A., Nguyen, Q. H., Andersen, S. B., Soyer, H. P., Frazer, I. H., & Powell, J. E. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.169 · Cited by 23
Single-Cell Technologies Applied to HIV-1 Research: Reaching Maturity
Sannier, G., Dubé, M., & Kaufmann, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00297 · Cited by 21
Latency Reversing Agents and the Road to an HIV Cure
Tioka, L., Diez, R. C., Sönnerborg, A., & van de Klundert, M. (2025) · Pathogens · doi:10.3390/pathogens14030232 · Cited by 20
Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy
Hong, F. F., Jacobs, J. L., Aga, E., Cillo, A. R., Fyne, E., Koontz, D. L., Zheng, L., & Mellors, J. W. (2018) · Virology · doi:10.1016/j.virol.2018.05.018 · Cited by 20
Self-citation
The Splice of Life: Does RNA Processing Have a Role in HIV-1 Persistence?
Pasternak, A. O., & Berkhout, B. (2021) · Viruses · doi:10.3390/v13091751 · Cited by 19
HibeRNAtion: HIV-1 RNA Metabolism and Viral Latency
Crespo, R., Rao, S., & Mahmoudi, T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.855092 · Cited by 22
The latent HIV reservoir: current advances in genetic sequencing approaches
Moar, P., Premeaux, T. A., Atkins, A., & Ndhlovu, L. C. (2023) · mBio · doi:10.1128/mbio.01344-23 · Cited by 23
Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy
Schwarzer, R., Gramatica, A., & Greene, W. C. (2020) · Viruses · doi:10.3390/v12020188 · Cited by 21
Structural and computational studies of HIV-1 RNA
Levintov, L., & Vashisth, H. (2023) · RNA Biology · doi:10.1080/15476286.2023.2289709 · Cited by 18
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda
Joussef-Piña, S., Nankya, I., Nalukwago, S., Baseke, J., Rwambuya, S., Winner, D., Kyeyune, F., Chervenak, K. A., Thiel, B., Asaad, R. J., et al. (2022) · Retrovirology · doi:10.1186/s12977-022-00587-3 · Cited by 17
HIV-1 reservoir dynamics in CD4+ T cells
Bruner, K. M., & Cohn, L. B. (2018) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000521 · Cited by 17
Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption
Prator, C. A., Thanh, C., Kumar, S., Pan, T., Peluso, M. J., Bosch, R. J., Jones, N. G., Milush, J. M., Bakkour, S., Stone, M., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz572 · Cited by 16
Silencing the transcriptionally active HIV reservoir to improve treatment outcomes
Kazmierski, J., Tavora, R., O’Brien, R. L. F., Schulze‐Gahmen, U., Boehm, D., Roan, N. R., Nixon, D. F., Ndhlovu, L. C., Valente, S. T., & Ott, M. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01816-5 · Cited by 15
A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro
Matsuda, K., Islam, S., Takada, T., Tsuchiya, K., Tan, B. J. Y., Hattori, S.-I., Katsuya, H., Kitagawa, K., Kim, K. S., Matsuo, M., et al. (2021) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100122 · Cited by 18
HIV-1 activates oxidative phosphorylation in infected CD4 T cells in a human tonsil explant model
Swartz, T. H., Freeman, T., Zhao, C., Schrode, N., Beaumont, K. G., Tweel, B. C., Fortune, T., & Schroff, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172938 · Cited by 14
The active human immunodeficiency virus reservoir during antiretroviral therapy: emerging players in viral persistence
Astorga-Gamaza, A., & Buzón, M. J. (2021) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000685 · Cited by 14
HIV reservoir quantification by five-target multiplex droplet digital PCR
Levy, C., Hughes, S. M., Roychoudhury, P., Amstuz, C., Zhu, H., Huang, M.-L. W., Lehman, D. A., Jerome, K. R., & Hladik, F. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100885 · Cited by 14
Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy
Moskovljevic, M., Dragoni, F., Nathan L. Board, Wu, F., Lai, J., Zhang, H., White, J. R., Hoh, R., Lynn, K., Tebas, P., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.11.002 · Cited by 17
Strategies for an HIV cure: progress and challenges
Wang, F. S., Zhang, L., Douek, D. C., McMichael, A. J., Xu, X., & Lewin, S. R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0242-8 · Cited by 13
The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells
Copertino, D. C., Holmberg, C. S., Weiler, J., Ward, A. R., Howard, J. N., Levinger, C., Pang, A. P. S., Corley, M. J., Dündar, F., Zumbo, P., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.169028 · Cited by 12
Self-citation
Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption
Wang, X., & Xu, H. (2021) · Viruses · doi:10.3390/v13020335 · Cited by 12
An Evaluation on the Role of Non-Coding RNA in HIV Transcription and Latency: A Review
Ramirez, P. W., Pantoja, C., & Beliakova‐Bethell, N. (2023) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s383347 · Cited by 12
Protocol for high-throughput reservoir quantification across global HIV subtypes using a cross-subtype intact proviral DNA assay
Fish, C. S., Cassidy, N. A. J., Levy, C., Hughes, S. M., Jerome, K. R., Overbaugh, J. M., Hladik, F., & Lehman, D. A. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101681 · Cited by 11
Cell Size-Based Decision-Making of a Viral Gene Circuit
Bohn-Wippert, K., Tevonian, E. N., Lu, Y., Huang, M.-Y., Megaridis, M. R., & Dar, R. D. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.009 · Cited by 12
Cure and Long-Term Remission Strategies
Mori, L., & Valente, S. T. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1871-4_26 · Cited by 10
Challenges and Promise of Human Immunodeficiency Virus Remission
Li, Y., Mohammadi, A., & Li, J. Z. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa568 · Cited by 10
The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV
Karuppusamy, K. V., Babu, P., & Thangavel, S. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10145-7 · Cited by 11
Genetically intact but functionally impaired HIV-1 env glycoproteins in the T-cell reservoir
de Verneuil, A., Migraine, J., Mammano, F., Molina, J.-M., Gallien, S., Mouquet, H., Hance, A. J., Clavel, F., & Dutrieux, J. (2018) · Journal of Virology · doi:10.1128/jvi.01684-17 · Cited by 10
Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth
Wang, X., Vincent, E., Siddiqui, S., Turnbull, K., Lü, H., Blair, R. V., Wu, X., Watkins, M., Ziani, W., Shao, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32554-z · Cited by 9
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus
Joseph, S., Abrahams, M.-R., Moeser, M., Tyers, L., Archin, N. M., Sondgeroth, A., Spielvogel, E., Emery, A., Zhou, S., Doolabh, D., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011974 · Cited by 10

Authors: Wiegand, A., Spindler, J., Hong, F. F., Shao, W., Cyktor, J. C., Cillo, A. R., Halvas, E. K., Coffin, J. M., Mellors, J. W., & Kearney, M. F.
Affiliations: National Cancer Institute (US)
University of Pittsburgh (US)
Frederick National Laboratory for Cancer Research (US)
Tufts University (US)
ORCID: Shao, Wei
Cyktor, Joshua C.
Cillo, Anthony R.
Halvas, Elias K.
Coffin, John M.
Mellors, John W.
Kearney, Mary F.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2017-04-17
Volume: 114
Issue: 18
Pages: E3659-E3668
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1617961114
PMC: PMC5422779
OpenAlex: W2606857030
Cited by: 165
References: 44
Citations by year: 2026: 8 · 2025: 19 · 2024: 15 · 2023: 17 · 2022: 15 · 2021: 19 · 2020: 25 · 2019: 19 · 2018: 23 · 2017: 4
FWCI: 10.57
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.pnas.org/site/misc/userlicense.xhtml (vor, 183 d)
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: HHS | NIH | National Cancer Institute (Intramural Funding, 1U01CA200441)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: HIV-1, unspliced viral RNA, single-genome sequencing, antiretroviral therapy, viral reservoir, defective proviruses, HIV transcription, viremia, blood mononuclear cells
MeSH terms: Female, Humans, Leukocytes, Mononuclear, Male, Proviruses, RNA, Viral, Transcription, Genetic, HIV-1, Gene Expression Regulation, Viral, Anti-Retroviral Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks